Ocean Genomics Names Five Prominent Oncology Researchers to Its Scientific Advisory Board

Pittsburgh, PA. March 2, 2020

Ocean Genomics is pleased to announce the following individuals have joined our scientific advisory board.  Each has significant experience in oncology and adoption of new technologies and techniques involving the study and treatment of cancer. 

Stanley M. Marks, MD
Chairman, UPMC Hillman Cancer Center
Director of Clinical Services and Chief Medical Officer, UPMC Hillman Cancer Center
Chief Division of Hematology Oncology, UPMC Shadyside
Clinical Professor of Medicine, University of Pittsburgh School of Medicine 

Edith Perez, MD
Professor of Medicine
Mayo Clinic
Jacksonville, FL   

David R. Gandara, MD
Professor of Medicine Emeritus
Director, Thoracic Oncology
Senior Advisor to the Director
UC Davis Comprehensive Cancer Center
Sacramento, CA 

Adrian Lee, PhD
Professor and Director, Institute for Precision Medicine
University of Pittsburgh
Pittsburgh, PA 

Justin Odegaard, MD, PhD
VP, Clinical Development 
Guardant Health
Redwood City, CA
Adjunct Clinical Assistant Professor of Medicine
Stanford University
Palo Alto, CA 

“We are delighted to have a scientific advisory board with such great leaders in the field of oncology”, said Carl Kingsford, Ph.D., Herbert A. Simon Professor of Computer Science in the Computational Biology Department in the School of Computer Science at Carnegie Mellon University and Co-founder and CEO of Ocean Genomics. 

About Ocean Genomics: Ocean Genomics, Inc. (oceangenomics.com) creates software to analyze gene expression and RNA sequencing data. Our mission is to provide the world’s most accurate, efficient, and comprehensive gene expression analyses by supporting and extending our current state-of-the-art gene expression and transcriptome analysis software and engaging with customers in programs of biomarker discovery and validation.  

For more information, see our website at oceangenomics.com, or contact us via email at contact@oceangenomics.com.